A plea was moved before Bombay HC on Saturday seeking direction to Drug Controller General of India (DCGI) to bring in public domain all information pertaining to safety and efficacy trial results of Bharat Biotech's COVID-19 vaccine Covaxin. This comes on the same day that the nationwide COVID-19 vaccination drive began in India. Covaxin has emergency use approval in India.
A plea was moved before Bombay HC on Saturday seeking direction to Drug Controller General of India (DCGI) to bring in public domain all information pertaining to safety and efficacy trial results of Bharat Biotech's COVID-19 vaccine Covaxin. This comes on the same day that the nationwide COVID-19 vaccination drive began in India. Covaxin has emergency use approval in India.